Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TKPHF) Liabilities from Discontinued Operations (2018 - 2025)

Historic Liabilities from Discontinued Operations for Takeda Pharmaceutical (TKPHF) over the last 7 years, with Q4 2025 value amounting to $5.1 million.

  • Takeda Pharmaceutical's Liabilities from Discontinued Operations changed N/A to $5.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $5.1 million, marking a year-over-year change of. This contributed to the annual value of $9.8 million for FY2024, which is 81724.36% up from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Liabilities from Discontinued Operations of $5.1 million as of Q4 2025.
  • In the past 5 years, Takeda Pharmaceutical's Liabilities from Discontinued Operations ranged from a high of $9.5 million in Q1 2024 and a low of $1.1 million during Q1 2023
  • For the 4-year period, Takeda Pharmaceutical's Liabilities from Discontinued Operations averaged around $6.3 million, with its median value being $5.7 million (2022).
  • Within the past 5 years, the most significant YoY rise in Takeda Pharmaceutical's Liabilities from Discontinued Operations was 77397.67% (2024), while the steepest drop was 77397.67% (2024).
  • Over the past 4 years, Takeda Pharmaceutical's Liabilities from Discontinued Operations (Quarter) stood at $8.3 million in 2022, then plummeted by 86.89% to $1.1 million in 2023, then surged by 745.6% to $9.2 million in 2024, then plummeted by 44.67% to $5.1 million in 2025.
  • Its Liabilities from Discontinued Operations stands at $5.1 million for Q4 2025, versus $4.9 million for Q3 2025 and $9.2 million for Q2 2024.